Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

PREFUSION PIV F IMMUNOGENS AND THEIR USE

  • Read more about PREFUSION PIV F IMMUNOGENS AND THEIR USE
European Patent
23156040.0
Filed on 2017-10-25

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS

  • Read more about RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS
France
16838103.6
Filed on 2016-12-12

Compositions And Methods For Treating Malaria

  • Read more about Compositions And Methods For Treating Malaria
Patent Cooperation Treaty
PCT/US2022/013223
Filed on 2022-01-22

COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY

  • Read more about COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY
Hong Kong
62022057259.3
Filed on 2022-07-25

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS

  • Read more about RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS
Ireland
16838103.6
Filed on 2016-12-12

Self-assembling Nanoparticles Based On Amphiphilic Peptides

  • Read more about Self-assembling Nanoparticles Based On Amphiphilic Peptides
Patent Cooperation Treaty
PCT/US2022/016600
Filed on 2022-02-16

CD47-targeted Therapies For The Treatment Of Infectious Disease

  • Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease
European Patent
22185801.2
Filed on 2022-07-19

Broadly Neutralizing and Potent Antibodies Against HIV

  • Read more about Broadly Neutralizing and Potent Antibodies Against HIV
US Application 17/778,536
Filed on 2022-05-20

Improvement Of HIV-neutralizing Antibodies By Modification Of The Heavy Chain FR3 Loop And Other Regions

  • Read more about Improvement Of HIV-neutralizing Antibodies By Modification Of The Heavy Chain FR3 Loop And Other Regions
European Patent
20892529.7
Filed on 2020-11-27

RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS

  • Read more about RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS
United Kingdom
16838103.6
Filed on 2016-12-12

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 146
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health